Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Cannabinoid 2 Receptor
62%
Cisplatin
50%
Diabetic Cardiomyopathy
48%
Cannabinoid
44%
Antioxidant
42%
Cannabinoid 2 Receptor Agonist
40%
Phytochemical
38%
Fibrosis
35%
Doxorubicin
33%
Eales Disease
33%
Liver Fibrosis
33%
Cardiotoxicity
33%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
33%
Cannabinoid 1 Receptor
33%
Reperfusion Injury
33%
Cannabidiol
33%
Tumor Necrosis Factor
30%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
24%
Nephrotoxicity
24%
Kidney Disease
23%
Endocannabinoid
23%
Kidney Injury
21%
Heart Infarction
20%
Diabetes Mellitus
20%
Drug Development
20%
Cardiovascular Disease
19%
Atherosclerosis
19%
Medicinal Plant
19%
Rimonabant
18%
Non Insulin Dependent Diabetes Mellitus
17%
Lysine
17%
3 Nitrotyrosine
17%
Tetrahydrocannabivarin
16%
Hepatitis
16%
STAT3 Protein
16%
Nonalcoholic Fatty Liver
16%
Broccoli
16%
Sulforaphane
16%
Hydroxyl Radical
16%
Protein Tyrosine Kinase
16%
Carbonyl Derivative
16%
Injury
16%
Carbene
16%
8 Hydroxydeoxyguanosine
16%
Heart Muscle Ischemia
16%
Phosphatidylinositol
16%
Fumaric Acid Dimethyl Ester
16%
Plasma Protein
16%
Lactosylceramide
16%
Keyphrases
PARP Inhibitor (PARPi)
20%
Pharmacological Inhibitors
19%
Pharmacognostical
16%
Poly (ADP-ribose) Polymerase Inhibition
16%
Polymicrobial Sepsis
16%
Myeloid Cells
16%
Gene Knockout Mice
16%
Signal Transducer and Activator of Transcription 3
16%
Bacterial Mortality
16%
Popular Medicine
16%
Nonalcoholic Steatohepatitis
16%
Liver Inflammation
16%
Bacterial Invasion
16%
Group Content
16%
Cannabidivarin
16%
α-galactosylceramide (α-GalCer)
16%
Dimethyl Fumarate
16%
Angiogenesis
16%
Myocardial Ischemic Injury
16%
Natural Components
16%
Eales Disease
16%
Hydroxyl Radical
16%
Cell Inflammation
16%
Iron Chelation
16%
Broccoli
16%
Sulforaphane
16%
Antifibrotic Action
16%
Inflammasome
16%
Natural Drugs
16%
Doxorubicin-induced Cardiomyopathy
16%
Electron Spin Resonance Spectroscopy
16%
Monocytes
16%
HU-910
16%
Oxidative Inactivation
16%
8-hydroxydeoxyguanosine (8-OHdG)
16%
Antioxidant Parameters
16%
Disease Implications
16%
Phosphatidylinositol 3
16%
Insulin Receptor Kinase
16%
Tuberculosis Arthritis
16%
Eales'
16%
Human Endothelial Cells
16%
HU-308
16%
Genipin
16%
Myocardial Ischemia Injury
16%
Resveratrol
16%
Azidothymidine
16%
Xanthine Oxidase Inhibitor
16%
Mitochondrial Reactive Oxygen Species (mtROS)
16%
Simultaneous Detection
16%
